Overview

Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function

Status:
Completed
Trial end date:
2019-06-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of K-877 in adult patients with fasting high triglyceride levels ≥500 mg/dL and <2000 mg/dL and normal renal function.
Phase:
Phase 3
Details
Lead Sponsor:
Kowa Research Institute, Inc.
Treatments:
Fenofibrate